Beta-cyclodextrin, 2-hydroxyethyl ethers is a modified cyclodextrin derivative used as a pharmaceutical excipient. Its primary significance lies in its ability to improve the aqueous solubility of poorly soluble drugs, facilitating their formulation and manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 128446-32-2
Melarsomine
veterinary antiparasitic agent
6-OH Alosetron
active pharmaceutical ingredient impurity
Romidepsin
active pharmaceutical ingredient
Dotinurad
selective urate reabsorption inhibitor
Beta-Cyclodextrin hydrate
drug solubilization agent and excipient
Beta-CYCLODEXTRIN
thickening and encapsulation agent
Heptakis(2,6-di-O-methyl)-beta-cyclodextrin
pharmaceutical solubilizer and stabilizer
(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30S,31S,33R,35R,36R,37S,38R,39S,40R,41S,42R,43S,44R,45S,46R,47S,48R,49S)-37,39,41,43,45,47,49-heptakis(2-hydroxyethoxy)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,38,40,42,44,46,48-heptol
PCWPQSDFNIFUPO-KCVBUHIQSA-N
C(CO[C@H]1[C@@H]([C@H]2[C@H](O[C@@H]1O[C@@H]3[C@H](O[C@@H]([C@H]([C@@H]3O)OCCO)O[C@@H]4[C@H](O[C@@H]([C@H]([C@@H]4O)OCCO)O[C@@H]5[C@H](O[C@@H]([C@H]([C@@H]5O)OCCO)O[C@@H]6[C@@H](O[C@@H]([C@H]([C@@H]6O)OCCO)O[C@@H]7[C@H](O[C@@H]([C@H]([C@@H]7O)OCCO)O[C@@H]8[C@H](O[C@H](O2)[C@H]([C@@H]8O)OCCO)CO)CO)CO)CO)CO)CO)CO)O)O
—